It has FDA approval
Glutathione IV Therapy is typically much shorter, depending on the individual and other nutrients
Significantly altered (C16 + C18:1)/C2 ratio was only observed in patients with gout
Conversely, in a recent randomized, double-blind, placebo-controlled study involving twenty healthy volunteers, a once-weekly injection of a GLP-1R agonist, dulaglutide, for three weeks did not influence HPA axis activity, showing no significant effects on circadian rhythms of blood or salivary cortisol secretion, and the level of this hormone also was not changed after the dexamethasone suppression test in comparison with the placebo-receiving group [78]
First, the heterogeneity among GLP-1RAs, particularly regarding their molecular structure and pharmacokinetics, may account for divergent cardiovascular outcomes